{"id":165955,"date":"2025-02-26T14:16:04","date_gmt":"2025-02-26T13:16:04","guid":{"rendered":"https:\/\/www.gpigroup.com\/?p=165955"},"modified":"2025-03-14T16:16:29","modified_gmt":"2025-03-14T15:16:29","slug":"la-drug-cell-est-nee","status":"publish","type":"post","link":"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/","title":{"rendered":"La Drug Cell est n\u00e9e"},"content":{"rendered":"<p><strong>La soci\u00e9t\u00e9 fran\u00e7aise \u00ab The Drug Cell \u00bb (TDC) vient d\u2019\u00eatre officiellement cr\u00e9\u00e9e, marquant une avanc\u00e9e d\u00e9cisive pour le secteur europ\u00e9en de la th\u00e9rapie cellulaire<\/strong>. Ce nouvel \u00e9cosyst\u00e8me industriel \u00e0 fort potentiel vise \u00e0 d\u00e9velopper des th\u00e9rapies cellulaires plus facilement accessibles et de grande envergure. The Drug Cell r\u00e9unit neuf acteurs fran\u00e7ais de premier plan dans le domaine de la biotechnologie et de l\u2019innovation : l\u2019Etablissement Fran\u00e7ais du Sang (EFS), le Centre d\u2019\u00c9tude des Cellules Souches\/I-Stem, GPI France, Carroucell, EVerZom, MGA Technologies, l\u2019Universit\u00e9 de Montpellier, le CHU de Montpellier et le CHU de Rennes.<\/p>\n<p>Cette \u00e9tape majeure s\u2019accompagne de la confirmation d\u2019un financement substantiel allou\u00e9 par le Secr\u00e9tariat G\u00e9n\u00e9ral pour l\u2019Investissement dans le cadre de l\u2019initiative \u00ab France 2030 \u00bb. Ces ressources permettront \u00e0 The Drug Cell de lancer et de mener \u00e0 bien les deux premi\u00e8res phases du projet : les travaux de recherche et d\u00e9veloppement ainsi que le Premier D\u00e9ploiement Industriel (PDI). Ce soutien strat\u00e9gique permettra d\u2019initier les premiers essais cliniques d\u2019ici 2030, pour une mise sur le march\u00e9 estim\u00e9e en 2034.<\/p>\n<p><strong>L\u2019entreprise entend s\u2019imposer comme un acteur de r\u00e9f\u00e9rence en France et en Europe dans le domaine de la m\u00e9decine r\u00e9g\u00e9n\u00e9rative et des th\u00e9rapies cellulaires de pointe<\/strong>. Sa priorit\u00e9 est de garantir l\u2019acc\u00e8s \u00e0 des bioth\u00e9rapies innovantes \u00e0 des co\u00fbts soutenables, posant ainsi les bases d\u2019un produit comp\u00e9titif \u00e0 l\u2019\u00e9chelle mondiale. Pour ce faire, elle mise sur l\u2019int\u00e9gration de technologies de pointe, o\u00f9 l\u2019automatisation, l\u2019intelligence artificielle et la fabrication num\u00e9rique permettront de r\u00e9duire les erreurs, d\u2019assurer un contr\u00f4le qualit\u00e9 en temps r\u00e9el et de renforcer l\u2019industrialisation des proc\u00e9d\u00e9s. Parall\u00e8lement, l\u2019utilisation de technologies disruptives propres \u00e0 TDC renforcera la comp\u00e9titivit\u00e9 et l\u2019autonomie de production des solutions d\u00e9velopp\u00e9es. Parmi les innovations majeures figure l\u2019emploi de la technologie de \u00ab jumeau num\u00e9rique \u00bb \u2013 des mod\u00e8les virtuels reproduisant le comportement cellulaire \u2013 d\u00e8s les premi\u00e8res \u00e9tapes de d\u00e9veloppement. Cette approche permettra de suivre et d\u2019adapter chaque th\u00e9rapie en temps r\u00e9el, optimisant ainsi les traitements avant m\u00eame leur phase de test chez les patients.<\/p>\n<p>Derni\u00e8rement, <strong>Sergio Manzana<\/strong> (GPI France) a \u00e9t\u00e9 nomm\u00e9 Pr\u00e9sident de The Drug Cell. Il a d\u00e9clar\u00e9 : \u00ab La cr\u00e9ation de The Drug Cell repr\u00e9sente un pas d\u00e9cisif vers l\u2019autonomie industrielle de l\u2019Europe en mati\u00e8re de production de th\u00e9rapies cellulaires, avec la France au c\u0153ur de cette r\u00e9volution. Nous proposerons de nouvelles solutions pour des maladies graves qui, \u00e0 ce jour, ne disposent pas de traitements efficaces, telles que les maladies rares ou g\u00e9n\u00e9tiques. Nous cr\u00e9ons un \u00e9cosyst\u00e8me in\u00e9dit r\u00e9unissant des acteurs publics et priv\u00e9s, afin de prouver, au travers de solutions concr\u00e8tes, l\u2019impact transformateur des technologies de sant\u00e9 sur la vie des personnes. \u00bb<\/p>\n<h4><a href=\"https:\/\/www.gpigroup.com\/app\/uploads\/2025\/02\/025-02-26-Gpi-PR-The-Drug-Cell-Established-04.pdf\">Lisez le communiqu\u00e9 de presse<\/a><\/h4>\n","protected":false},"excerpt":{"rendered":"<p>Une nouvelle alliance fran\u00e7aise pour red\u00e9finir les th\u00e9rapies cellulaires<\/p>\n","protected":false},"author":38,"featured_media":159422,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[888,351,1414],"tags":[],"class_list":["post-165955","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-investisseurs-fr","category-investisseurs","category-nouvelle"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La Drug Cell est n\u00e9e | GPI<\/title>\n<meta name=\"description\" content=\"La soci\u00e9t\u00e9 fran\u00e7aise vient d\u2019\u00eatre officiellement cr\u00e9\u00e9e, marquant une avanc\u00e9e d\u00e9cisive pour le secteur europ\u00e9en de la th\u00e9rapie cellulaire\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La Drug Cell est n\u00e9e | GPI\" \/>\n<meta property=\"og:description\" content=\"La soci\u00e9t\u00e9 fran\u00e7aise vient d\u2019\u00eatre officiellement cr\u00e9\u00e9e, marquant une avanc\u00e9e d\u00e9cisive pour le secteur europ\u00e9en de la th\u00e9rapie cellulaire\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/\" \/>\n<meta property=\"og:site_name\" content=\"GPI\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/GruppoGPI\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-26T13:16:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-14T15:16:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.gpigroup.com\/app\/uploads\/2024\/11\/drug-cell-post-ENG.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Federico Pessot\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Federico Pessot\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/\"},\"author\":{\"name\":\"Federico Pessot\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#\/schema\/person\/1f333989923a8e557c9d5ec39c78990f\"},\"headline\":\"La Drug Cell est n\u00e9e\",\"datePublished\":\"2025-02-26T13:16:04+00:00\",\"dateModified\":\"2025-03-14T15:16:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/\"},\"wordCount\":522,\"publisher\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.gpigroup.com\/app\/uploads\/2024\/11\/drug-cell-post-ENG.png\",\"articleSection\":[\"Investisseurs\",\"Investisseurs\",\"Nouvelle\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/\",\"url\":\"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/\",\"name\":\"La Drug Cell est n\u00e9e | GPI\",\"isPartOf\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.gpigroup.com\/app\/uploads\/2024\/11\/drug-cell-post-ENG.png\",\"datePublished\":\"2025-02-26T13:16:04+00:00\",\"dateModified\":\"2025-03-14T15:16:29+00:00\",\"description\":\"La soci\u00e9t\u00e9 fran\u00e7aise vient d\u2019\u00eatre officiellement cr\u00e9\u00e9e, marquant une avanc\u00e9e d\u00e9cisive pour le secteur europ\u00e9en de la th\u00e9rapie cellulaire\",\"breadcrumb\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/#primaryimage\",\"url\":\"https:\/\/www.gpigroup.com\/app\/uploads\/2024\/11\/drug-cell-post-ENG.png\",\"contentUrl\":\"https:\/\/www.gpigroup.com\/app\/uploads\/2024\/11\/drug-cell-post-ENG.png\",\"width\":1200,\"height\":1200,\"caption\":\"The Drug Cell - The revolution in cell therapies\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.gpigroup.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La Drug Cell est n\u00e9e\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#website\",\"url\":\"https:\/\/www.gpigroup.com\/fr\/\",\"name\":\"GPI\",\"description\":\"The Healthcare Partner\",\"publisher\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.gpigroup.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#organization\",\"name\":\"GPI S.p.A.\",\"url\":\"https:\/\/www.gpigroup.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.gpigroup.com\/app\/uploads\/2023\/03\/logo-GPI-2019-1.jpg\",\"contentUrl\":\"https:\/\/www.gpigroup.com\/app\/uploads\/2023\/03\/logo-GPI-2019-1.jpg\",\"width\":1946,\"height\":1945,\"caption\":\"GPI S.p.A.\"},\"image\":{\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/GruppoGPI\/\",\"https:\/\/www.linkedin.com\/company\/gpi-spa\",\"http:\/\/www.youtube.com\/user\/GruppoGPI\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#\/schema\/person\/1f333989923a8e557c9d5ec39c78990f\",\"name\":\"Federico Pessot\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.gpigroup.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/01567a0a2e721b2e07509a56aef0c812074367509e3cd0488de6731c8be7c002?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/01567a0a2e721b2e07509a56aef0c812074367509e3cd0488de6731c8be7c002?s=96&d=mm&r=g\",\"caption\":\"Federico Pessot\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La Drug Cell est n\u00e9e | GPI","description":"La soci\u00e9t\u00e9 fran\u00e7aise vient d\u2019\u00eatre officiellement cr\u00e9\u00e9e, marquant une avanc\u00e9e d\u00e9cisive pour le secteur europ\u00e9en de la th\u00e9rapie cellulaire","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/","og_locale":"fr_FR","og_type":"article","og_title":"La Drug Cell est n\u00e9e | GPI","og_description":"La soci\u00e9t\u00e9 fran\u00e7aise vient d\u2019\u00eatre officiellement cr\u00e9\u00e9e, marquant une avanc\u00e9e d\u00e9cisive pour le secteur europ\u00e9en de la th\u00e9rapie cellulaire","og_url":"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/","og_site_name":"GPI","article_publisher":"https:\/\/www.facebook.com\/GruppoGPI\/","article_published_time":"2025-02-26T13:16:04+00:00","article_modified_time":"2025-03-14T15:16:29+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/www.gpigroup.com\/app\/uploads\/2024\/11\/drug-cell-post-ENG.png","type":"image\/png"}],"author":"Federico Pessot","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Federico Pessot","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/#article","isPartOf":{"@id":"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/"},"author":{"name":"Federico Pessot","@id":"https:\/\/www.gpigroup.com\/fr\/#\/schema\/person\/1f333989923a8e557c9d5ec39c78990f"},"headline":"La Drug Cell est n\u00e9e","datePublished":"2025-02-26T13:16:04+00:00","dateModified":"2025-03-14T15:16:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/"},"wordCount":522,"publisher":{"@id":"https:\/\/www.gpigroup.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/#primaryimage"},"thumbnailUrl":"https:\/\/www.gpigroup.com\/app\/uploads\/2024\/11\/drug-cell-post-ENG.png","articleSection":["Investisseurs","Investisseurs","Nouvelle"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/","url":"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/","name":"La Drug Cell est n\u00e9e | GPI","isPartOf":{"@id":"https:\/\/www.gpigroup.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/#primaryimage"},"image":{"@id":"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/#primaryimage"},"thumbnailUrl":"https:\/\/www.gpigroup.com\/app\/uploads\/2024\/11\/drug-cell-post-ENG.png","datePublished":"2025-02-26T13:16:04+00:00","dateModified":"2025-03-14T15:16:29+00:00","description":"La soci\u00e9t\u00e9 fran\u00e7aise vient d\u2019\u00eatre officiellement cr\u00e9\u00e9e, marquant une avanc\u00e9e d\u00e9cisive pour le secteur europ\u00e9en de la th\u00e9rapie cellulaire","breadcrumb":{"@id":"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/#primaryimage","url":"https:\/\/www.gpigroup.com\/app\/uploads\/2024\/11\/drug-cell-post-ENG.png","contentUrl":"https:\/\/www.gpigroup.com\/app\/uploads\/2024\/11\/drug-cell-post-ENG.png","width":1200,"height":1200,"caption":"The Drug Cell - The revolution in cell therapies"},{"@type":"BreadcrumbList","@id":"https:\/\/www.gpigroup.com\/fr\/news\/la-drug-cell-est-nee\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gpigroup.com\/fr\/"},{"@type":"ListItem","position":2,"name":"La Drug Cell est n\u00e9e"}]},{"@type":"WebSite","@id":"https:\/\/www.gpigroup.com\/fr\/#website","url":"https:\/\/www.gpigroup.com\/fr\/","name":"GPI","description":"The Healthcare Partner","publisher":{"@id":"https:\/\/www.gpigroup.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gpigroup.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.gpigroup.com\/fr\/#organization","name":"GPI S.p.A.","url":"https:\/\/www.gpigroup.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.gpigroup.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.gpigroup.com\/app\/uploads\/2023\/03\/logo-GPI-2019-1.jpg","contentUrl":"https:\/\/www.gpigroup.com\/app\/uploads\/2023\/03\/logo-GPI-2019-1.jpg","width":1946,"height":1945,"caption":"GPI S.p.A."},"image":{"@id":"https:\/\/www.gpigroup.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/GruppoGPI\/","https:\/\/www.linkedin.com\/company\/gpi-spa","http:\/\/www.youtube.com\/user\/GruppoGPI"]},{"@type":"Person","@id":"https:\/\/www.gpigroup.com\/fr\/#\/schema\/person\/1f333989923a8e557c9d5ec39c78990f","name":"Federico Pessot","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.gpigroup.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/01567a0a2e721b2e07509a56aef0c812074367509e3cd0488de6731c8be7c002?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/01567a0a2e721b2e07509a56aef0c812074367509e3cd0488de6731c8be7c002?s=96&d=mm&r=g","caption":"Federico Pessot"}}]}},"_links":{"self":[{"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/posts\/165955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/comments?post=165955"}],"version-history":[{"count":5,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/posts\/165955\/revisions"}],"predecessor-version":[{"id":167560,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/posts\/165955\/revisions\/167560"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/media\/159422"}],"wp:attachment":[{"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/media?parent=165955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/categories?post=165955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gpigroup.com\/fr\/wp-json\/wp\/v2\/tags?post=165955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}